These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33689835)

  • 1. Induction of Contralateral Hepatic Hypertrophy by Unilobar Yttrium-90 Transarterial Radioembolization versus Portal Vein Embolization: An Animal Study.
    Liebl M; Pedersoli F; Zimmermann M; Schulze-Hagen M; Truhn D; Sieben P; von Stillfried S; Tschinaev A; Heinzel A; Kuhl CK; Bruners P; Isfort P
    J Vasc Interv Radiol; 2021 Jun; 32(6):836-842.e2. PubMed ID: 33689835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioembolization versus portal vein embolization for contralateral liver lobe hypertrophy: effect of cirrhosis.
    Nebelung H; Wolf T; Bund S; Radosa CG; Plodeck V; Grosche-Schlee S; Riediger C; Hoffmann RT; Kühn JP
    Abdom Radiol (NY); 2021 Aug; 46(8):4046-4055. PubMed ID: 33779787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma.
    Gabr A; Abouchaleh N; Ali R; Baker T; Caicedo J; Katariya N; Abecassis M; Riaz A; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2018 Nov; 29(11):1502-1510.e1. PubMed ID: 30268638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contra-lateral liver lobe hypertrophy after unilobar Y90 radioembolization: an alternative to portal vein embolization?
    Teo JY; Goh BK
    World J Gastroenterol; 2015 Mar; 21(11):3170-3. PubMed ID: 25805922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Portal Vein Embolization Using a Simplified Sheathless 18-Gauge Trocar Needle Approach: Review of Efficacy and Safety.
    Wong SS; Yuen BT; Lee RK; Tsai CS; Cheung YS; Lee KF; Yu SCH
    J Vasc Interv Radiol; 2019 Mar; 30(3):440-444. PubMed ID: 30819490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization.
    Garlipp B; de Baere T; Damm R; Irmscher R; van Buskirk M; Stübs P; Deschamps F; Meyer F; Seidensticker R; Mohnike K; Pech M; Amthauer H; Lippert H; Ricke J; Seidensticker M
    Hepatology; 2014 May; 59(5):1864-73. PubMed ID: 24259442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential Y
    Addeo P; de Mathelin P; De Marini P; Greget M; Bachellier P
    Langenbecks Arch Surg; 2023 Aug; 408(1):339. PubMed ID: 37639197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Radiation Dose Absorbed by Healthy Parenchyma Is a Predictor for the Rate of Contralateral Hypertrophy After Unilobar Radioembolization of the Right Liver.
    Coskun N; Yildirim A; Yuksel AO; Canyigit M; Ozdemir E
    Nucl Med Mol Imaging; 2022 Dec; 56(6):291-298. PubMed ID: 36425272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal Vein Embolization Utilizing N-Butyl Cyanoacrylate for Contralateral Lobe Hypertrophy Prior to Liver Resection: A Systematic Review and Meta-Analysis.
    Wajswol E; Jazmati T; Contractor S; Kumar A
    Cardiovasc Intervent Radiol; 2018 Sep; 41(9):1302-1312. PubMed ID: 29687262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial versus transhepatic portal vein embolization to induce selective hepatic hypertrophy: a comparative study in swine.
    Madoff DC; Gupta S; Pillsbury EP; Kan Z; Tinkey PT; Stephens LC; Ensor JE; Hicks ME; Wright KC
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):79-93. PubMed ID: 17296708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future liver remnant growth after various portal vein embolization regimens: a quantitative comparison.
    Biggemann L; Uhlig J; Streit U; Sack H; Guo XC; Jung C; Ahmed S; Lotz J; Müller-Wille R; Seif Amir Hosseini A
    Minim Invasive Ther Allied Technol; 2020 Apr; 29(2):98-106. PubMed ID: 30821547
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic Hypertrophy in Normal and Cirrhotic Livers Following Portal Vein Embolization: Comparative Assessment of 2 Different Embolic Regimens in a Large Animal Model.
    Kuhn TN; Kahl VH; Wang Y; Berz AM; Shewarega A; Santana JG; Antoch G; Chapiro J; Schlachter T; Madoff DC
    J Vasc Interv Radiol; 2023 Dec; 34(12):2162-2172.e2. PubMed ID: 37634850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with
    Hermann AL; Dieudonné A; Ronot M; Sanchez M; Pereira H; Chatellier G; Garin E; Castera L; Lebtahi R; Vilgrain V;
    Radiology; 2020 Sep; 296(3):673-684. PubMed ID: 32602828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with
    Luz JHM; Veloso Gomes F; Costa NV; Vasco I; Coimbra E; Luz PM; Marques HP; Coelho JS; Mega RMA; Ribeiro VNTV; da Costa Lamelas JTR; de Sampaio Nunes E Sobral MM; da Silva SRG; de Teixeira Carrelha AS; Rodrigues SCC; de Figueiredo AAFP; Santos MV; Bilhim T
    Radiology; 2021 Jun; 299(3):715-724. PubMed ID: 33825512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90.
    Teo JY; Allen JC; Ng DC; Choo SP; Tai DW; Chang JP; Cheah FK; Chow PK; Goh BK
    HPB (Oxford); 2016 Jan; 18(1):7-12. PubMed ID: 26776845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic Changes after Yttrium-90 Radioembolization of Colorectal Liver Metastases: A Pilot Feasibility Study.
    Kitsel Y; Vakiani E; Kirov A; Zirakchian Zadeh M; Kunin H; Petre EN; Crane CH; Romesser P; Sotirchos VS; Sofocleous CT
    J Vasc Interv Radiol; 2024 Jul; 35(7):1012-1021.e1. PubMed ID: 38670528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal vein embolization using a Histoacryl/Lipiodol mixture before right liver resection.
    Bellemann N; Stampfl U; Sommer CM; Kauczor HU; Schemmer P; Radeleff BA
    Dig Surg; 2012; 29(3):236-42. PubMed ID: 22797287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limits of and Complications after Embolization of the Hepatic Artery and Portal Vein to Induce Segmental Hypertrophy of the Liver: A Large Mini-Pig Study.
    Heits N; Mueller L; Koops A; Koops S; Herrmann J; Hendricks A; Kabar I; Arlt A; Braun F; Becker T; Wilms C
    Eur Surg Res; 2016; 57(3-4):155-170. PubMed ID: 27434375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series.
    Zheng J; Irani Z; Lawrence D; Flaherty K; Arellano RS
    J Vasc Interv Radiol; 2018 Oct; 29(10):1369-1375. PubMed ID: 30174161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma.
    Johnson GE; Monsky WL; Valji K; Hippe DS; Padia SA
    J Vasc Interv Radiol; 2016 Aug; 27(8):1123-9. PubMed ID: 27321889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.